News + Filings Holdings
All
13F
13D/G
Other
|
|
IDG-Accel China Growth Fund III Associates L.P.
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 11/15/2021 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 08/16/2021 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 06/03/2021 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 02/11/2021 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 11/10/2020 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 08/05/2020 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 06/05/2020 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 03/06/2020 |
13F-HR/A
| Form 13F-HR/A - Quarterly report filed by institutional managers, Holdings: [Amend] |
| 03/23/2018 |
4
| IDG-Accel China Growth Fund III L.P. (10% Owner) has filed a Form 4 on CASI Pharmaceuticals, Inc.|
Txns:
| Bought 2,882,098 shares
@ $3.19, valued at
$9.2M
Bought 204,320 shares
@ $3.19, valued at
$651.8k
Bought 1,152,839 warrants
@ $3.69, valued at
$4.3M
Bought 1,152,839 warrants
@ $3.69, valued at
$4.3M
|
|
|
|